COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020
Shana Godfred‐Cato, Bobbi Bryant, Jessica Leung, Matthew E. Oster, Laura Conklin, Joseph Y. Abrams, Katherine Roguski, Bailey Wallace, Emily Prezzato, Emilia H. Koumans, Ellen H. Lee, Anita Geevarughese, Maura K. Lash, Kathleen H. Reilly, W Pulver, Deepam Thomas, Kenneth A. Feder, Katherine Hsu, Nottasorn Plipat, Gillian Richardson, Heather Reid, Sarah Lim, Ann Schmitz, Timmy Pierce, Susan Hrapcak, Deblina Datta, Sapna Bamrah Morris, Kevin R. Clarke, Ermias D. Belay, California MIS-C Response Team
Abstract
Median duration of hospitalization was 6 days; 364 patients (63.9%) required care in an intensive care unit (ICU), and 10 patients (1.8%) died. As the COVID-19 pandemic continues to expand in many jurisdictions, clinicians should be aware of the signs and symptoms of MIS-C and report suspected cases to their state or local health departments; analysis of reported cases can enhance understanding of MIS-C and improve characterization of the illness for early detection and treatment.